<html>
<head>PUBMED IDs for HSAN1</head>
<body bgcolor='#C5F0F2'><h1>HSAN1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22045570/'>Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.</a> February 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22328086/'>Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy.</a> September 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23365052/'>DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss.</a> April 20  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25033457/'>Aberrant signature methylome by DNMT1 hot spot mutation in hereditary sensory and autonomic neuropathy 1E.</a> July 21  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26232991/'>Molecular pathogenesis, experimental therapy and genetic counseling in hereditary sensory neuropathies.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26573920/'>The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy.</a> December 29  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26681808/'>HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.</a> December 15  2015<br></body></html>
